JPET Introducing ALZET?ew Model 2006 Pump

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Hellstrom, P. M.
Right arrow Articles by Makhlouf, G. M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Hellstrom, P. M.
Right arrow Articles by Makhlouf, G. M.

Coexistence of three tachykinin receptors coupled to Ca++ signaling pathways in intestinal muscle cells

PM Hellstrom, KS Murthy, JR Grider and GM Makhlouf

Department of Medicine, Medical College of Virginia, Richmond.

Receptors for tachykinins and the signaling pathway to which they are coupled were characterized in dispersed muscle cells from the longitudinal muscle layer of the rat intestine. A technique of receptor protection whereby selective agonists and antagonists were used to protect one receptor while other receptors were inactivated with N- ethylmaleimide enabled each tachykinin receptor type to be identified separately. Protection of neurokinin (NK)-1 receptors with the selective NK-1 agonist, substance P methylester, or antagonist, GR- 82,334 (Glp-Ala-Asp-Pro-Asn-Lys-Phe-Tyr-D-Pro[spiro-gamma-lactam]Leu- Trp-NH2), preserved the contractile response and increase in cytosolic- free Ca++ ([Ca++]i) induced by substance P methylester only; protection of NK-2 receptors with the selective NK-2 agonist, beta-[Ala8]NKA(4- 10), or the selective NK-2b antagonist, L-659,877 [cyclo(Leu-Met-Gln- Trp-Phe-Gly)], preserved the contractile response and increase in [Ca++]i induced by beta-[Ala8]NKA(4-10) only; and protection of NK-3 receptors with the selective NK-3 agonist, senktide succinyl- [Asp6,MePhe8]substance P(6-11), preserved the contractile response and increase in [Ca++]i induced by succinyl-[Asp6,MePhe8]substance P(6-11) only. When used as a protective agent, the NK-2a antagonist, MEN-10,376 (H-Asp-Tyr-D-Trp-Val-D-Trp-D-Trp-Lys-NH2), did not preserve the response to any tachykinin agonist. Protection of NK-1, NK-2 and NK-3 receptors preserved fully the responses to the preferential endogenous agonists, substance P, NKA and NKB, respectively, but they also preserved in part (30-40%) the responses to the nonpreferential agonists. Because substance P and NKA are coreleased from the same precursor in intestinal muscle tissue, the pattern implied the existence of considerable spareness in the contractile response of muscle cells to tachykinins. Studies on dispersed circular muscle cells using selective tachykinin agonists as protective agents confirmed the presence of three tachykinin receptor types. The results demonstrate the coexistence of NK-1, NK-2b and NK-3 receptors on muscle cells of rat intestine that are preferentially activated by substance P, NKA and NKB, respectively, and are coupled separately to one signaling pathway mediating contraction.

Volume 270, Issue 1, pp. 236-243, 07/01/1994
Copyright © 1994 by American Society for Pharmacology and Experimental Therapeutics




This article has been cited by other articles:


Home page
Am. J. Physiol. Gastrointest. Liver Physiol.Home page
W. Hu, S. Mahavadi, J. Huang, F. Li, and K. S. Murthy
Characterization of S1P1 and S1P2 receptor function in smooth muscle by receptor silencing and receptor protection
Am J Physiol Gastrointest Liver Physiol, October 1, 2006; 291(4): G605 - G610.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Gastrointest. Liver Physiol.Home page
W. Cao, M. D. Vrees, M. T. Kirber, C. Fiocchi, and V. E. Pricolo
Hydrogen peroxide contributes to motor dysfunction in ulcerative colitis
Am J Physiol Gastrointest Liver Physiol, May 1, 2004; 286(5): G833 - G843.
[Abstract] [Full Text] [PDF]


Home page
Arch SurgHome page
M. D. Vrees, V. E. Pricolo, F. M. Potenti, and W. Cao
Abnormal Motility in Patients With Ulcerative Colitis: The Role of Inflammatory Cytokines
Arch Surg, April 1, 2002; 137(4): 439 - 446.
[Abstract] [Full Text] [PDF]


Home page
IOVSHome page
A. Grumann-Júnior, M. A. Dias, R. V. Alves, J. E. Boteon, and J. B. Calixto
Mechanisms Mediating Substance P-Induced Contraction in the Rat Iris In Vitro
Invest. Ophthalmol. Vis. Sci., June 1, 2000; 41(7): 1861 - 1870.
[Abstract] [Full Text]


Home page
J. Pharmacol. Exp. Ther.Home page
J. M. Goldhill, T. Shea-Donohue, N. Ali, and V. M. Piñeiro-Carrero
Tachykinergic Neurotransmission Is Enhanced in Small Intestinal Circular Muscle in a Rabbit Model of Inflammation
J. Pharmacol. Exp. Ther., September 1, 1997; 282(3): 1373 - 1378.
[Abstract] [Full Text]


Home page
J. Biol. Chem.Home page
K. S. Murthy and G. M. Makhlouf
Differential Coupling of Muscarinic m2 and m3 Receptors to Adenylyl Cyclases V/VI in Smooth Muscle. CONCURRENT m2-MEDIATED INHIBITION VIA Galpha i3 AND m3-MEDIATED STIMULATION VIA Gbeta gamma q
J. Biol. Chem., August 22, 1997; 272(34): 21317 - 21324.
[Abstract] [Full Text] [PDF]




Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 1994 by the American Society for Pharmacology and Experimental Therapeutics.